Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer
Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada
Forte Minerals Corp Exhibits at PDAC 2026, Highlighting the Alto Ruri Project's High-Grade Potential Near Barrick's Pierina Mine
NextSource Materials Announces Closing of $25 Million LIFE Offering to Advance UAE Battery Anode Facility
Canadian Securities Exchange Approves Gold Runner Exploration's Option to Acquire the Golden Girl Property from the B-ALL Syndicate in British Columbia's Prolific Golden Triangle
